Hereditary Transthyretin Amyloid Cardiomyopathy

Quentin Riggins Youmans; Sanjiv J. Shah; Sadiya S. Khan

doi:10.1001/jamacardio.2021.5006

Hereditary Transthyretin Amyloid Cardiomyopathy

Quentin Riggins Youmans, Sanjiv J. Shah, Sadiya S. Khan

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	236
Number of pages	1
Journal	JAMA cardiology
Volume	7
Issue number	2
DOIs	https://doi.org/10.1001/jamacardio.2021.5006
State	Published - Feb 2022

Funding

Published Online: December 22, 2021. doi:10.1001/jamacardio.2021.5006 Author Affiliations: Northwestern University, Chicago, Illinois. Conflict of Interest Disclosures: Dr Shah reported grants from Pfizer and consulting fees from Pfizer, Ionis Pharmaceuticals, Eidos, Prothena, and Regeneron outside the submitted work. Dr Khan reported grants from the American Heart Association and the National Institutes of Health outside the submitted work. No other disclosures were reported.

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2021.5006

Cite this

@article{477ac61720a9410588d6ad22d17e3999,

title = "Hereditary Transthyretin Amyloid Cardiomyopathy",

author = "Youmans, {Quentin Riggins} and Shah, {Sanjiv J.} and Khan, {Sadiya S.}",

note = "Funding Information: Published Online: December 22, 2021. doi:10.1001/jamacardio.2021.5006 Author Affiliations: Northwestern University, Chicago, Illinois. Conflict of Interest Disclosures: Dr Shah reported grants from Pfizer and consulting fees from Pfizer, Ionis Pharmaceuticals, Eidos, Prothena, and Regeneron outside the submitted work. Dr Khan reported grants from the American Heart Association and the National Institutes of Health outside the submitted work. No other disclosures were reported.",

year = "2022",

month = feb,

doi = "10.1001/jamacardio.2021.5006",

language = "English (US)",

volume = "7",

pages = "236",

journal = "JAMA cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "2",

}

TY - JOUR

T1 - Hereditary Transthyretin Amyloid Cardiomyopathy

AU - Youmans, Quentin Riggins

AU - Shah, Sanjiv J.

AU - Khan, Sadiya S.

N1 - Funding Information: Published Online: December 22, 2021. doi:10.1001/jamacardio.2021.5006 Author Affiliations: Northwestern University, Chicago, Illinois. Conflict of Interest Disclosures: Dr Shah reported grants from Pfizer and consulting fees from Pfizer, Ionis Pharmaceuticals, Eidos, Prothena, and Regeneron outside the submitted work. Dr Khan reported grants from the American Heart Association and the National Institutes of Health outside the submitted work. No other disclosures were reported.

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85122058605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122058605&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2021.5006

DO - 10.1001/jamacardio.2021.5006

M3 - Comment/debate

C2 - 34935856

AN - SCOPUS:85122058605

SN - 2380-6583

VL - 7

SP - 236

JO - JAMA cardiology

JF - JAMA cardiology

IS - 2

ER -

Hereditary Transthyretin Amyloid Cardiomyopathy

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this